EDGAR Filing Documents for 0001654954-17-004355

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-17-004355

Filing Date

2017-05-10

Accepted

2017-05-10 17:05:24

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	navb_form10-q.htm	10-Q	922822
2	LATKIN EMPLOYMENT AGREEMENT	navb_ex10-6.htm	EX-10.6	82191
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	navb_ex31-1.htm	EX-31.1	10930
4	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	navb_ex31-2.htm	EX-31.2	10958
5	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	navb_ex32-1.htm	EX-32.1	6479
6	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	navb_ex32-2.htm	EX-32.2	6576
	Complete submission text file	0001654954-17-004355.txt		3713656

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	navb-20170331.xml	EX-101.INS	524350
8	XBRL TAXONOMY EXTENSION SCHEMA	navb-20170331.xsd	EX-101.SCH	43282
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	navb-20170331_cal.xml	EX-101.CAL	63057
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	navb-20170331_def.xml	EX-101.DEF	83275
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	navb-20170331_lab.xml	EX-101.LAB	346074
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	navb-20170331_pre.xml	EX-101.PRE	247382

Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017

Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)